Exact Mass: 410.0849
Exact Mass Matches: 410.0849
Found 302 metabolites which its exact mass value is equals to given mass value 410.0849
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicosulfuron
CONFIDENCE standard compound; EAWAG_UCHEM_ID 129 CONFIDENCE standard compound; INTERNAL_ID 2532
BENSULFURON-METHYL
spirodiclofen
Ceftibuten
Ceftibuten is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic. It is an orally-administered agent. Cefalexin is used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Aklaviketone
A carboxylic ester that is the methyl ester of (1R,2R)-2-ethyl-2,5,7-trihydroxy-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid.
MM 42842
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Tanomastat
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
JNJ-42165279
D004791 - Enzyme Inhibitors JNJ-42165279 is a FAAH inhibitor that inhibits hFAAH and rFAAH with IC50 of 70±8 nM and 313 ± 28 nM respectively.
BMS-707035
D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
3-(4-Hydroxybenzoyl)epicatechin
3-(4-Hydroxybenzoyl)epicatechin is found in tea. 3-(4-Hydroxybenzoyl)epicatechin is isolated from oolong tea (Camellia sinensis var. assamica). Isolated from oolong tea (Camellia sinensis variety assamica). Epicatechin 3-p-hydroxybenzoate is found in tea.
7,11,12-Triacetoxycoumestan
Animal growth stimulan
Bms-707035
D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
Ethametsulfuron-methyl
Phenobarbital N-glucoside
(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Aloenin
Aloenin is a glycoside. Aloenin is a natural product found in Aloe africana, Aloe nyeriensis, and other organisms with data available. See also: Aloe Vera Leaf (part of). Aloenin (Aloenin A) is a natural compound, which has potent peroxyl radical-scavenging activities and moderate inhibitory active on β-secretase (BACE)[1][2]. Aloenin (Aloenin A) is a natural compound, which has potent peroxyl radical-scavenging activities and moderate inhibitory active on β-secretase (BACE)[1][2].
Dehydropodophyllotoxin
Dehydropodophyllotoxin is a natural product found in Hernandia ovigera, Juniperus sabina, and other organisms with data available.
DIMETHYL (2Z,3Z)-2,3-BIS(BENZO[1,3]DIOXOL-5-YLMETHYLIDENE)BUTANEDIOATE
CP-544439
CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4198; ORIGINAL_PRECURSOR_SCAN_NO 4197 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4199; ORIGINAL_PRECURSOR_SCAN_NO 4198 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4224; ORIGINAL_PRECURSOR_SCAN_NO 4223 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4201; ORIGINAL_PRECURSOR_SCAN_NO 4200 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4288; ORIGINAL_PRECURSOR_SCAN_NO 4287 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4161; ORIGINAL_PRECURSOR_SCAN_NO 4159 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8355; ORIGINAL_PRECURSOR_SCAN_NO 8351 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8380; ORIGINAL_PRECURSOR_SCAN_NO 8377 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8404; ORIGINAL_PRECURSOR_SCAN_NO 8401 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8406; ORIGINAL_PRECURSOR_SCAN_NO 8401 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8384; ORIGINAL_PRECURSOR_SCAN_NO 8379 CONFIDENCE standard compound; INTERNAL_ID 416; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8413; ORIGINAL_PRECURSOR_SCAN_NO 8410
3-[4-(4-Chlorobenzoyl)-1-methyl-1H-pyrrol-2-yl]-2-(phenylsulfonyl)acrylonitrile
11-hydroxy-13-chloro-11,13-dihydroatripliciolide-8-O-tiglate
7-nor-6-oxo-2,3-dehydro-12abeta-hydroxyrotenone|7-nor-6-oxo-4,5-dehydrorotenolone
Desertorin A
A bicoumarin that is 7-hydroxy-4-methoxy-5-methyl-2H-chromen-2-one substituted by a 7-hydroxy-4-methoxy-5-methyl-2-oxo-2H-chromen-6-yl group at position 8.
(1R,3S,4S,5S,6S,7R,8S)-4beta-(chloromethyl)-3beta,4alpha-dihydroxy-8alpha-(3-formyl-2-methyl-propenoyloxy)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide
7-hydroxy-4,5,6-trimethoxy-3,4-methylenedioxy-2,7-cycloling-7,8-diene-9,9-lactone
9-ethyl-1,4,6,7-tetrahydroxy-10-methoxycarbonyl-7,8-dihydro-5,12-naphthacenequinone|Anhydro-epsilon-pyrromycinone
6-[4-hydroxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-4-methoxypyran-2-one
2-(hydroxymethyl)-5-(2-oxopropyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
BENSULFURON-METHYL
The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
Ala Cys Cys Asp
Ala Cys Asp Cys
Ala Cys Met Ser
Ala Cys Ser Met
Ala Asp Cys Cys
Ala Met Cys Ser
Ala Met Ser Cys
Ala Ser Cys Met
Ala Ser Met Cys
Cys Ala Cys Asp
Cys Ala Asp Cys
Cys Ala Met Ser
Cys Ala Ser Met
Cys Cys Ala Asp
Cys Cys Asp Ala
Cys Cys Glu Gly
Cys Cys Gly Glu
Cys Cys Ser Val
Cys Cys Val Ser
Cys Asp Ala Cys
Cys Asp Cys Ala
Cys Asp Ser Ser
Cys Glu Cys Gly
Cys Glu Gly Cys
Cys Gly Cys Glu
Cys Gly Glu Cys
Cys Gly Met Thr
Cys Gly Thr Met
Cys Met Ala Ser
Cys Met Gly Thr
Cys Met Ser Ala
Cys Met Thr Gly
Cys Ser Ala Met
Cys Ser Cys Val
Cys Ser Asp Ser
Cys Ser Met Ala
Cys Ser Ser Asp
Cys Ser Val Cys
Cys Thr Gly Met
Cys Thr Met Gly
Cys Val Cys Ser
Cys Val Ser Cys
Asp Ala Cys Cys
Asp Cys Ala Cys
Asp Cys Cys Ala
Asp Cys Ser Ser
cis-3-(6-Hydroxy-7-methoxy-5-benzofuranyl)acrylic acid glucuronide
Asp Ser Cys Ser
Asp Ser Ser Cys
Glu Cys Cys Gly
Glu Cys Gly Cys
Glu Gly Cys Cys
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-hydroxy-4-oxo- glucuronide
Gly Cys Cys Glu
Gly Cys Glu Cys
Gly Cys Met Thr
Gly Cys Thr Met
Gly Glu Cys Cys
Gly Met Cys Thr
Gly Met Thr Cys
Gly Thr Cys Met
Gly Thr Met Cys
Met Ala Cys Ser
Met Ala Ser Cys
Met Cys Ala Ser
Met Cys Gly Thr
Met Cys Ser Ala
Met Cys Thr Gly
Met Gly Cys Thr
Met Gly Thr Cys
Met Ser Ala Cys
Met Ser Cys Ala
Met Thr Cys Gly
Met Thr Gly Cys
Ser Ala Cys Met
Ser Ala Met Cys
Ser Cys Ala Met
Ser Cys Cys Val
Ser Cys Asp Ser
Ser Cys Met Ala
Ser Cys Ser Asp
Ser Cys Val Cys
Ser Asp Cys Ser
Ser Asp Ser Cys
Ser Met Ala Cys
Ser Met Cys Ala
Ser Ser Cys Asp
Ser Ser Asp Cys
Ser Val Cys Cys
Thr Cys Gly Met
Thr Cys Met Gly
Thr Gly Cys Met
Thr Gly Met Cys
Thr Met Cys Gly
Thr Met Gly Cys
Val Cys Cys Ser
Val Cys Ser Cys
Val Ser Cys Cys
Stimol 410
3-(4-Hydroxybenzoyl)epicatechin
4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydro-imidazo[5,1-f][1,2,4]-triazin-2-yl)benzene-sulfonyl Chloride
2-(4-((6-BROMO-3-NITROQUINOLIN-4-YL)AMINO)PHENYL)-2-METHYLPROPANENITRILE
Phosphonium,(3-methyl-2-buten-1-yl)triphenyl-, bromide (1:1)
(S)-tert-butyl 2-(5-(4-bromophenyl)-1h-imidazol-2-yl)pyrrolidine-1-carboxylate
3-(1h-imidazol-4-yl)propyl(4-bromophenyl)methyl ether, maleic acid
Phosphonic acid, [[1-[[(methylsulfonyl)oxy]methyl]-2-(phenylmethoxy)ethoxy]methyl]-, diethyl ester-R
4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzene-1-sulfonyl chloride
[4-(5-bromo-2-chloro-benzyl)-phenoxy]-tert-butyl-dimethyl-silane
benzenesulfonyl chloride;1,4-divinylbenzene;styrene
2-Propenamide-3-(2-chlorophenyl)-N-[2-[[3-(dimethylamino)propyl]thio]phenyl]-hydrochloride(1:1)
N-methyl ,ethyl-Morpholinium bis((trifluoromethyl)sulfonyl)imide
4-[4-(4-Chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid
2-[[5-(2-furanyl)-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]-N-(2-methoxyphenyl)acetamide
2-[[2-methyl-5-nitro-3-(phenylmethyl)-4-imidazolyl]thio]-6-nitro-1H-benzimidazole
2H-Pyran-4-carboxamide, 4-(((4-(4-fluorophenoxy)phenyl)sulfonyl)amino)tetrahydro-N-hydroxy-
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors
4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid
(S)-1-[2-Deoxy-3,5-O-(1-phosphono)benzylidene-B-D-threo-pentofuranosyl]thymine
Diclofenac Epolamine
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
4-[[[3-(6-Methoxypyridin-3-yl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]benzenesulfonamide
5-Ethyl-5-phenyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3-diazinane-2,4,6-trione
1-(2-Hydroxyethyl)pyrrolidinium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
ethyl 2-chloro-5-[5-[(E)-(5-cyano-4-methyl-2,6-dioxopyridin-3-ylidene)methyl]furan-2-yl]benzoate
1-(4-aminofurazan-3-yl)-N-[1-(3-hydroxyphenyl)ethylideneamino]-5-(2-thienyl)triazole-4-carboxamide
4-{[(E)-(3-bromo-4-hydroxy-5-methoxyphenyl)methylidene]amino}-5-cyclohexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
N-[3-(dimethylamino)propyl]-N-(6-methyl-1,3-benzothiazol-2-yl)-1,3-benzothiazole-6-carboxamide
N-[3-(4-methyl-1-piperidinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide
5-O-phosphono-2-deoxyribosyl-(3->5)-2-deoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2-deoxy-alpha-D-ribofuranos-5-yl group.
2-Deoxy-5-(4,5-dihydroxypentyl)uridine 5-monophosphate
A pyrimidine 2-deoxyribonucleoside 5-monophosphate having 5-(4,5-dihydroxypentyl)uracil as the nucleobase.
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[3-(phenylmethyl)-2-imidazo[4,5-b]pyridinyl]thio]acetamide
6-[3-(cyclopropylmethoxy)-4-methoxyphenyl]-3-(2-fluorophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
(1R,5S)-3-(2-fluorophenyl)sulfonyl-7-[4-(5-pyrimidinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
[2-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] naphthalene-2-sulfonate
3,4,5-Trihydroxy-6-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]oxyoxane-2-carboxylic acid
6-[1-Carboxy-2-(4-methoxy-1-benzofuran-5-yl)-2-oxoethyl]-3,4,5-trihydroxyoxane-2-carboxylic acid
[2-Hydroxy-2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-2-yl]propyl] hydrogen sulate
2-(hydroxymethyl)-5-(2-oxopropyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Ceftibuten
A third-generation cephalosporin antibiotic with a [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino substituent at the 7 position of the cephem skeleton. An orally-administered agent, ceftibuten is used as the dihydrate to treat urinary-tract and respiratory-tract infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
IEM-1754
IEM-1754, a dicationic adamantane derivative, is a potent blocker of open channels of native ionotropic glutamate receptors including quisqualate-sensitive receptors in insect muscles, NMDAR in cultured rat cortical neurons, and AMPAR in freshly isolated hippocampal cells. IEM-1754 shows anticonvulsant potency in vivo[1][2].
LUF6000
LUF6000 is an orally active allosteric modulator of the A3 adenosine receptor. LUF6000 has potent anti-inflammatory effect[1][2].
SIRT2/6-IN-1
SIRT2/6-IN-1 (Compound 5) is a SIRT6/SIRT2 inhibitor, with IC50s of 106 μM and 114 μM. SIRT2/6-IN-1 increases H3K9 acetylation, increases glucose uptake and reduces TNF-α secretion in cells[1].